Lori Kunkel

Dr. Kunkel has led successful clinical development programs at several life sciences companies, most recently as Chief Medical Officer at Pharmacyclics (acquired by AbbVie) and Proteolix, Inc. (acquired by Onyx Pharmaceuticals). Prior to this, she was Vice President of Clinical Development at Xencor, Inc., and began her career in the industry as a clinical scientist at Genentech.